Search Results

There are 9496 results for: content related to: Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

  1. You have free access to this content
    Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension

    Journal of Bone and Mineral Research

    Volume 19, Issue 8, August 2004, Pages: 1259–1269, Kristine E Ensrud, Elizabeth L Barrett-Connor, Ann Schwartz, Arthur C Santora, Douglas C Bauer, Shailaja Suryawanshi, Adrianne Feldstein, William L Haskell, Marc C Hochberg, James C Torner, Antonio Lombardi, Dennis M Black and for the Fracture Intervention Trial Long-Term Extension Research Group

    Version of Record online : 29 MAR 2004, DOI: 10.1359/JBMR.040326

  2. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

    Intervention Review

    The Cochrane Library

    George A Wells, Ann Cranney, Joan Peterson, Michel Boucher, Beverley Shea, Vivian Welch, Doug Coyle and Peter Tugwell

    Published Online : 23 JAN 2008, DOI: 10.1002/14651858.CD001155.pub2

  3. You have free access to this content
    Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: Evaluation of transdermal absorption, safety, and pharmacological effects after application in rats

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 9, September 2012, Pages: 3230–3238, Hidemasa Katsumi, Shu Liu, Yutaro Tanaka, Kaori Hitomi, Rie Hayashi, Yuka Hirai, Kosuke Kusamori, Ying-shu Quan, Fumio Kamiyama, Toshiyasu Sakane and Akira Yamamoto

    Version of Record online : 29 MAR 2012, DOI: 10.1002/jps.23136

  4. You have free access to this content
    Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis

    Journal of Bone and Mineral Research

    Volume 25, Issue 12, December 2010, Pages: 2582–2591, Kosuke Kusamori, Hidemasa Katsumi, Mari Abe, Asuka Ueda, Ryota Sakai, Rie Hayashi, Yuka Hirai, Ying-shu Quan, Fumio Kamiyama, Toshiyasu Sakane and Akira Yamamoto

    Version of Record online : 7 JUN 2010, DOI: 10.1002/jbmr.147

  5. Generic alendronate use among medicare beneficiaries: are part d data complete?

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 55–63, Huifeng Yun, Jeffrey R Curtis, Kenneth Saag, Meredith Kilgore, Paul Muntner, Wilson Smith, Robert Matthews, Nicole Wright, Michael A. Morrisey and Elizabeth Delzell

    Version of Record online : 8 NOV 2012, DOI: 10.1002/pds.3361

  6. You have free access to this content
    Development of polyethylene glycol-conjugated alendronate, a novel nitrogen-containing bisphosphonate derivative: Evaluation of absorption, safety, and effects after intrapulmonary administration in rats

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 9, September 2011, Pages: 3783–3792, Hidemasa Katsumi, Miki Takashima, Jun-Ichi Sano, Kazushi Nishiyama, Noriko Kitamura, Toshiyasu Sakane, Toru Hibi and Akira Yamamoto

    Version of Record online : 12 MAY 2011, DOI: 10.1002/jps.22620

  7. You have free access to this content
    ASBMR 25th Annual Meeting M001–M483

    Journal of Bone and Mineral Research

    Volume 18, Issue S1, 2003, Pages: S285–S393,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650181306

  8. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 3, March 2011, Pages: 400–408, Jian Meng and Liandong Hu

    Version of Record online : 8 FEB 2011, DOI: 10.1111/j.2042-7158.2010.01229.x

  9. Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate

    Macromolecular Bioscience

    Volume 16, Issue 5, May 2016, Pages: 717–729, Kambiz Farbod, Mani Diba, Tatiana Zinkevich, Stephan Schmidt, Matthew J. Harrington, Arno P. M. Kentgens and Sander C. G. Leeuwenburgh

    Version of Record online : 15 JAN 2016, DOI: 10.1002/mabi.201500414

  10. You have free access to this content
    Local administration of alendronate reduced peri-tunnel bone loss and promoted graft-bone tunnel healing with minimal systemic effect on bone in contralateral knee

    Journal of Orthopaedic Research

    Volume 31, Issue 12, December 2013, Pages: 1897–1906, Pauline Po Yee Lui, Yuk Wa Lee, Tsui Yu Mok and Yau Chuk Cheuk

    Version of Record online : 22 JUL 2013, DOI: 10.1002/jor.22442

  11. Use of bisphosphonates in the management of postmenopausal osteoporosis

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 15–32, Socrates E. Papapoulos

    Version of Record online : 29 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05767.x

  12. You have free access to this content
    ASBMR 29th Annual Meeting

    Journal of Bone and Mineral Research

    Volume 22, Issue S1, September 2007, Pages: s302–s351,

    Version of Record online : 4 MAR 2010, DOI: 10.1002/jbmr.5650221408

  13. You have free access to this content
    ASBMR 26th Annual Meeting M001–M585

    Journal of Bone and Mineral Research

    Volume 19, Issue S1, 2004, Pages: S343–S484,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650191306

  14. You have free access to this content
    ASBMR 27th Annual Meeting M001–M525

    Journal of Bone and Mineral Research

    Volume 20, Issue S1, 11 August 2005, Pages: S313–S437,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650201306

  15. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation

    Journal of Cellular Physiology

    Volume 230, Issue 8, August 2015, Pages: 1944–1953, Lindsay M. Coe, Srinivasan Arjun Tekalur, Yutian Shu, Melissa J. Baumann and Laura R. McCabe

    Version of Record online : 27 APR 2015, DOI: 10.1002/jcp.24929

  16. You have free access to this content
    ASBMR 27th Annual Meeting SU001–SU527

    Journal of Bone and Mineral Research

    Volume 20, Issue S1, 11 August 2005, Pages: S190–S313,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650201305

  17. Interventions for the treatment of decreased bone mineral density associated with HIV infection

    Intervention Review

    The Cochrane Library

    Daren Lin and Michael J Rieder

    Published Online : 18 APR 2007, DOI: 10.1002/14651858.CD005645.pub2

  18. You have free access to this content
    Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study

    Journal of Bone and Mineral Research

    Volume 20, Issue 1, January 2005, Pages: 141–151, Clifford J Rosen, Marc C Hochberg, Sydney L Bonnick, Michael McClung, Paul Miller, Susan Broy, Risa Kagan, Erluo Chen, Richard A Petruschke, Desmond E Thompson and Anne E de Papp

    Version of Record online : 29 SEP 2004, DOI: 10.1359/JBMR.040920

  19. You have free access to this content
    Alendronate improves bone mineral density in primary biliary cirrhosis: A randomized placebo-controlled trial

    Hepatology

    Volume 42, Issue 4, October 2005, Pages: 762–771, Claudia O. Zein, Roberta A. Jorgensen, Bart Clarke, Doris E. Wenger, Jill C. Keach, Paul Angulo and Keith D. Lindor

    Version of Record online : 20 SEP 2005, DOI: 10.1002/hep.20866

  20. Effects of Alendronate on A Disintegrin and Metalloproteinase with Thrombospondin Motifs Expression in the Developing Epiphyseal Cartilage in Rats

    Anatomia, Histologia, Embryologia

    Volume 38, Issue 2, April 2009, Pages: 154–160, M. S. Kim, J. H. Kim, M. R. Lee, J. H. Kang, H. J. Kim, H. M. Ko, C. H. Choi, J. Y. Jung, J. T. Koh, B. K. Kim, H. K. Oh, W. J. Kim, E. J. Lee and S. H. Kim

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1439-0264.2008.00920.x